Zimmer Biomet Holdings ROA 2010-2025 | ZBH
Current and historical return on assets (ROA) values for Zimmer Biomet Holdings (ZBH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Zimmer Biomet Holdings ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $0.91B | $22.18B | 4.21% |
| 2024-12-31 | $0.90B | $21.37B | 4.20% |
| 2024-09-30 | $1.08B | $21.72B | 5.03% |
| 2024-06-30 | $1.00B | $21.52B | 4.65% |
| 2024-03-31 | $0.96B | $21.45B | 4.51% |
| 2023-12-31 | $1.03B | $21.50B | 4.81% |
| 2023-09-30 | $0.48B | $21.22B | 2.24% |
| 2023-06-30 | $0.51B | $21.29B | 2.39% |
| 2023-03-31 | $0.45B | $21.24B | 2.12% |
| 2022-12-31 | $0.23B | $21.07B | 1.09% |
| 2022-09-30 | $0.28B | $21.33B | 1.26% |
| 2022-06-30 | $0.23B | $21.45B | 1.01% |
| 2022-03-31 | $0.22B | $21.62B | 0.93% |
| 2021-12-31 | $0.40B | $23.46B | 1.68% |
| 2021-09-30 | $0.82B | $24.01B | 3.40% |
| 2021-06-30 | $0.92B | $24.22B | 3.80% |
| 2021-03-31 | $0.57B | $24.03B | 2.37% |
| 2020-12-31 | $-0.14B | $24.42B | -0.57% |
| 2020-09-30 | $-0.15B | $24.03B | -0.62% |
| 2020-06-30 | $0.04B | $23.65B | 0.15% |
| 2020-03-31 | $0.38B | $25.51B | 1.53% |
| 2019-12-31 | $1.13B | $24.64B | 4.65% |
| 2019-09-30 | $-0.09B | $24.32B | -0.37% |
| 2019-06-30 | $-0.36B | $24.21B | -1.47% |
| 2019-03-31 | $-0.31B | $24.29B | -1.24% |
| 2018-12-31 | $-0.38B | $24.13B | -1.48% |
| 2018-09-30 | $1.75B | $25.38B | 6.74% |
| 2018-06-30 | $1.69B | $25.49B | 6.43% |
| 2018-03-31 | $1.69B | $27.18B | 6.37% |
| 2017-12-31 | $1.81B | $26.01B | 6.85% |
| 2017-09-30 | $0.65B | $26.42B | 2.45% |
| 2017-06-30 | $0.71B | $26.46B | 2.66% |
| 2017-03-31 | $0.50B | $26.99B | 1.86% |
| 2016-12-31 | $0.31B | $26.68B | 1.16% |
| 2016-09-30 | $0.36B | $27.04B | 1.37% |
| 2016-06-30 | $0.23B | $25.97B | 0.86% |
| 2016-03-31 | $0.08B | $26.30B | 0.31% |
| 2015-12-31 | $0.15B | $27.16B | 0.59% |
| 2015-09-30 | $0.17B | $26.69B | 0.83% |
| 2015-06-30 | $0.32B | $27.20B | 2.00% |
| 2015-03-31 | $0.67B | $17.19B | 5.81% |
| 2014-12-31 | $0.72B | $9.66B | 7.52% |
| 2014-09-30 | $0.83B | $9.67B | 8.64% |
| 2014-06-30 | $0.81B | $9.64B | 8.52% |
| 2014-03-31 | $0.78B | $9.38B | 8.37% |
| 2013-12-31 | $0.78B | $9.58B | 8.48% |
| 2013-09-30 | $0.68B | $9.36B | 7.49% |
| 2013-06-30 | $0.70B | $9.10B | 7.88% |
| 2013-03-31 | $0.77B | $8.75B | 8.70% |
| 2012-12-31 | $0.76B | $9.01B | 8.64% |
| 2012-09-30 | $0.76B | $8.78B | 8.81% |
| 2012-06-30 | $0.77B | $8.62B | 9.12% |
| 2012-03-31 | $0.76B | $8.60B | 9.09% |
| 2011-12-31 | $0.76B | $8.52B | 9.21% |
| 2011-09-30 | $0.64B | $8.20B | 7.86% |
| 2011-06-30 | $0.64B | $8.25B | 7.90% |
| 2011-03-31 | $0.60B | $8.12B | 7.52% |
| 2010-12-31 | $0.60B | $8.00B | 7.54% |
| 2010-09-30 | $0.72B | $8.00B | 9.12% |
| 2010-06-30 | $0.68B | $7.83B | 8.70% |
| 2010-03-31 | $0.72B | $7.82B | 9.38% |
| 2009-12-31 | $0.72B | $7.79B | 9.52% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $18.948B | $7.679B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.835B | 28.36 |
| Boston Scientific (BSX) | United States | $157.798B | 39.50 |
| Stryker (SYK) | United States | $150.649B | 31.50 |
| EssilorLuxottica (ESLOY) | France | $134.205B | 0.00 |
| Medtronic (MDT) | Ireland | $111.543B | 16.29 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.908B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.033B | 27.90 |
| ResMed (RMD) | United States | $37.148B | 27.90 |
| GE HealthCare Technologies (GEHC) | United States | $33.471B | 15.89 |
| Agilent Technologies (A) | United States | $32.342B | 21.36 |
| Terumo (TRUMY) | Japan | $27.583B | 35.83 |
| Insulet (PODD) | United States | $22.931B | 90.01 |
| Koninklijke Philips (PHG) | Netherlands | $22.436B | 16.13 |
| Baxter (BAX) | United States | $16.150B | 12.06 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.745B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.231B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.767B | 23.55 |
| Lantheus Holdings (LNTH) | United States | $5.414B | 13.66 |
| Prestige Consumer Healthcare (PBH) | United States | $4.395B | 19.63 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.484B | 15.18 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.396B | 25.05 |
| Envista Holdings (NVST) | United States | $3.000B | 24.93 |
| QuidelOrtho (QDEL) | United States | $2.203B | 15.15 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| LeMaitre Vascular (LMAT) | United States | $1.942B | 43.41 |
| AtriCure (ATRC) | United States | $1.604B | 0.00 |
| Neogen (NEOG) | United States | $1.389B | 17.78 |
| Kestra Medical Technologies (KMTS) | United States | $1.245B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.213B | 12.31 |
| Green Thumb Industries (GTBIF) | United States | $1.175B | 26.43 |
| BioLife Solutions (BLFS) | United States | $1.090B | 0.00 |
| InMode (INMD) | Israel | $1.011B | 9.25 |
| Phibro Animal Health (PAHC) | United States | $0.978B | 12.50 |
| CeriBell (CBLL) | United States | $0.644B | 0.00 |
| Evolus (EOLS) | United States | $0.638B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.566B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.553B | 0.00 |
| Owens & Minor (OMI) | United States | $0.548B | 4.54 |
| Valneva SE (VALN) | France | $0.530B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.474B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.456B | 0.00 |
| Surmodics (SRDX) | United States | $0.422B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.342B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.330B | 12.14 |
| Canopy Growth (CGC) | Canada | $0.302B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.300B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.282B | 50.20 |
| Sanara MedTech (SMTI) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.50 |
| Sanuwave Health (SNWV) | United States | $0.253B | 0.00 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.250B | 0.00 |
| ZimVie (ZIMV) | United States | $0.244B | 11.08 |
| Biote (BTMD) | United States | $0.222B | 6.25 |
| Brainsway (BWAY) | Israel | $0.201B | 53.25 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| Omeros (OMER) | United States | $0.195B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Quanterix (QTRX) | United States | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.41 |
| Organigram Global (OGI) | Canada | $0.175B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.167B | 0.00 |
| Exagen (XGN) | United States | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.130B | 15.94 |
| Jin Medical (ZJYL) | China | $0.126B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| Agape ATP (ATPC) | $0.102B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Fonar (FONR) | United States | $0.084B | 10.81 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.060B | 0.00 |
| United Health Products (UEEC) | United States | $0.058B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.050B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.040B | 13.69 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.71 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Acuren (TIC) | United States | $0.000B | 0.00 |